|
The Immunohistochemistry Antibody Company
|
|
|
Blood Vessel Cancer 1 Tissue Microarray - LS-SBVCA1This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SBVCA1 |
| Product Name: | Blood Vessel Cancer 1 |
| Description: | Various blood vessel diseases (blood vessel cancer progression) |
| Format: | FFPE |
| Category: | Human Tumor Progression |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | No |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 80 |
| Cores: | 80 |
| Slides Per Set: | 1 |
LS-SBVCA1 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Blood vessel (Blo); Blood vessel, Wall and adventitia tissue (Blo); Brain, Cerebrum (Brn); Fallopian tube (Fal); Fibrous tissue (Fib); Heart (Hrt); Ligament (Lig); Liver (Liv); Lung (Lng); Mesentery (Mes); Skin (Skn); Spleen (Spl); Thyroid (Tyd); Tongue (Tng); Vulva (Vul);
LS-SBVCA1 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type |
|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 47 y | Heart (Hrt) | Angiosarcoma | Malignant |
| 1 | A2 | Human | M | 16 y | Fibrous tissue (Fib) | Angiosarcoma | Malignant |
| 1 | A3 | Human | M | 80 y | Liver (Liv) | Angiosarcoma | Malignant |
| 1 | A4 | Human | F | 65 y | Blood vessel (Blo) | Angiosarcoma | Malignant |
| 1 | A5 | Human | F | 65 y | Fallopian tube (Fal) | Angiosarcoma | Malignant |
| 1 | A6 | Human | M | 42 y | Spleen (Spl) | Angiosarcoma | Malignant |
| 1 | A7 | Human | F | 49 y | Lung (Lng) | Hemangiopericytoma | Malignant |
| 1 | A8 | Human | F | 56 y | Skin (Skn) | Hemangiopericytoma | Malignant |
| 1 | A9 | Human | F | 31 y | Heart (Hrt) | Hemangioendothelioma, Intermediate, Epithelioid | Tumor |
| 1 | A10 | Human | F | 16 y | Skin (Skn) | Hemangioendothelioma, Intermediate | Tumor |
| 1 | B1 | Human | F | 60 y | Skin (Skn) | Hemangioendothelioma, Intermediate, Epithelioid | Tumor |
| 1 | B2 | Human | F | 30 y | Ligament (Lig) | Hemangioendothelioma, Intermediate, Spindle cell | Tumor |
| 1 | B3 | Human | F | 38 y | Blood vessel (Blo) | Hemangioendothelioma, Intermediate | Tumor |
| 1 | B4 | Human | F | 43 y | Blood vessel (Blo) | Hemangioendothelioma, Intermediate | Tumor |
| 1 | B5 | Human | M | 32 y | Mesentery (Mes) | Hemangioma, Venous | Diseased |
| 1 | B6 | Human | M | 1 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | B7 | Human | M | 45 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | B8 | Human | M | 32 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | B9 | Human | M | 42 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | B10 | Human | F | 48 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C1 | Human | F | 48 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C2 | Human | F | 49 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C3 | Human | F | 35 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C4 | Human | M | 44 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C5 | Human | F | 60 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C6 | Human | F | 22 y | Brain, Cerebrum (Brn) | Hemangioma, Cavernous | Diseased |
| 1 | C7 | Human | M | 63 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C8 | Human | F | 38 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | C9 | Human | M | 0.3 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | C10 | Human | F | 62 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D1 | Human | M | 40 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D2 | Human | M | 0.4 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | D3 | Human | M | 56 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D4 | Human | F | 52 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D5 | Human | M | 71 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D6 | Human | M | 49 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D7 | Human | M | 41 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D8 | Human | F | 52 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D9 | Human | M | 46 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | D10 | Human | F | 42 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E1 | Human | M | 39 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E2 | Human | M | 53 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E3 | Human | F | 40 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E4 | Human | F | 46 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E5 | Human | M | 47 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E6 | Human | M | 56 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E7 | Human | M | 37 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E8 | Human | F | 47 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E9 | Human | F | 35 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | E10 | Human | M | 34 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F1 | Human | M | 60 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F2 | Human | F | 40 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F3 | Human | F | 42 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F4 | Human | F | 61 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F5 | Human | M | 37 y | Liver (Liv) | Hemangioma, Cavernous | Diseased |
| 1 | F6 | Human | F | 20 y | Tongue (Tng) | Granulomatous hemangioma with necrosis | Diseased |
| 1 | F7 | Human | M | 35 y | Brain, Cerebrum (Brn) | Hemangioma, Cavernous | Diseased |
| 1 | F8 | Human | M | 23 y | Spleen (Spl) | Hemangioma, Cavernous | Diseased |
| 1 | F9 | Human | F | 40 y | Tongue (Tng) | Hemangioma, Cavernous | Diseased |
| 1 | F10 | Human | M | 11 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | G1 | Human | F | 50 y | Thyroid (Tyd) | Hemangioma, Cavernous | Diseased |
| 1 | G2 | Human | M | 24 y | Skin (Skn) | Granulomatous hemangioma | Diseased |
| 1 | G3 | Human | F | 0.3 y | Skin (Skn) | Hemangioma, Capillary | Diseased |
| 1 | G4 | Human | F | 27 y | Skin (Skn) | Hemangioma, Cavernous | Diseased |
| 1 | G5 | Human | F | 42 y | Vulva (Vul) | Hemangioma, Cavernous | Diseased |
| 1 | G6 | Human | F | 12 y | Skin (Skn) | Granulomatous hemangioma | Diseased |
| 1 | G7 | Human | F | 65 y | Blood vessel (Blo) | Hemangioma, Cavernous | Diseased |
| 1 | G8 | Human | M | 62 y | Spleen (Spl) | Hemangioma, Cavernous | Diseased |
| 1 | G9 | Human | M | 55 y | Spleen (Spl) | Hemangioma, Cavernous | Diseased |
| 1 | G10 | Human | F | 50 y | Blood vessel (Blo) | Phlebitis with thrombus | Inflammatory |
| 1 | H1 | Human | F | 14 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H2 | Human | F | 42 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H3 | Human | M | 24 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H4 | Human | F | 28 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H5 | Human | F | 58 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H6 | Human | F | 21 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H7 | Human | M | 40 y | Blood vessel, Wall and adventitia tissue (Blo) | Normal | Benign non-neoplastic |
| 1 | H8 | Human | M | 35 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H9 | Human | M | 50 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |
| 1 | H10 | Human | M | 26 y | Blood vessel (Blo) | Normal | Benign non-neoplastic |